A

Advancing Vision Research, LLC | Smyrna, TN

Research site

(Unclaimed)

Location

515 Stonecrest Parkway Suite 210, Smyrna, Tennessee, United States of America

Site insights

Top conditions

Top treatments

AR-15512

AGN-190584

Bimatoprost

TL-925

AGN-242428

PL9643

SAF312

HL036

Tanfanercept

Perfluorohexyloctane

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 21 total trials

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

In this prospective, phase 2b, multicenter, randomized, double-masked, vehicle-controlled, parallel-arm study, approximately 880 subjects with modera...

Active, not recruiting

Dry Eye Disease

Drug: TL-925

Other: Placebo

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Active, not recruiting

Open-angle Glaucoma

Ocular Hypertension

Other: Sham Administration

Drug: AGN-193408 SR

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the effica...

Enrolling

Atopic Keratoconjunctivitis

Drug: Dupilumab

Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis

In this prospective, Phase 2, randomized, double-masked, vehicle controlled study, approximately 60 eligible subjects will be randomized 1:1 to recei...

Enrolling

Allergic Conjunctivitis

Drug: TL-925

Drug: Placebo